Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 57.46% is 43% below its 5-year average of 100.00%, near the high end of its 5-year range (-52.07%–100.00%).
10.52% below its 12-month average of 64.22%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
57.46%
GROSS MARGIN AVG TTM
64.22%
GROSS MARGIN AVG 3Y
100.00%
GROSS MARGIN AVG 5Y
100.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-10.52%
CURRENT VS 3Y AVG
-42.54%
CURRENT VS 5Y AVG
-42.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 500 covered companies
CURRENT VS SECTOR MEDIAN
+21.78%
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.42M
Gross Margin
57.46%
TTM Avg
64.22%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$33.52M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
Market Cap
$32.31M
Gross Margin
41.73%
TTM Avg
31.44%
3Y Avg
27.18%
5Y Avg
29.99%
Market Cap
$31.36M
Gross Margin
83.79%
TTM Avg
85.97%
3Y Avg
84.60%
5Y Avg
84.69%
Market Cap
$35.89M
Gross Margin
27.73%
TTM Avg
29.89%
3Y Avg
31.55%
5Y Avg
33.94%
Market Cap
$30.92M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.42M | 57.46% | 64.22% | 100.00% | 100.00% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | 0.00% | 0.00% | 10.20% |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | 0.00% | 0.00% | 25.00% | 50.00% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 41.73% | 31.44% | 27.18% | 29.99% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 83.79% | 85.97% | 84.60% | 84.69% |
| Accuray Incorporated (ARAY)vs › | $35.89M | 27.73% | 29.89% | 31.55% | 33.94% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $36.05M | 30.12% | 32.64% | 32.93% | 33.24% |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
57.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | -52.07% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 73.16% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 42.51% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
